News
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
1don MSN
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results